drug
lisinopril
Marketedupdated 3mo agoby CorePharma LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 6indications
investigational
Hypertension
all catalysts(0)
nothing on the calendar yet
Trials studying lisinopril
- phase3A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
- phase2Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria
- phase1A Study of Enlicitide Decanoate (MK-0616), Warfarin, and Lisinopril in Healthy Adult Participants (MK-0616-026)
- phase4Prophylactic Lisinopril to Prevent Anthracycline Cardiomyopathy.
- phase4Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.
- N/AWomen With Chest Pain and Normal Coronary Arteries Study
Patent cliff
source: FDA Orange Bookfirst barrier falls
Nov 6, 2035
~9.2 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (12)
- Nov 6, 2035method-of-use (U-185)US 10039800
- Nov 6, 2035formulationUS 10265370
- Nov 6, 2035method-of-use (U-8)US 10406199
- Nov 6, 2035formulationUS 10940177
- Nov 6, 2035formulationUS 11179434
- Nov 6, 2035formulationUS 11771733
- Nov 6, 2035formulationUS 12128083
- Nov 6, 2035formulationUS 12186360
- Nov 6, 2035method-of-use (U-3)US 12433931
- Nov 6, 2035formulationUS 9463183
- Nov 6, 2035method-of-use (U-71)US 9616096
- Nov 6, 2035formulationUS 9814751
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that